Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Acetate[1] Acetate---[41] 1, 2, 6, 10, 13, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 171, 206, 222, 224, 225, 227, 235, 251, 265, 288, 298, 299 💬
2Betamethasone[1] Betamethasone[1] Betamethasone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[8] 2, 28, 46, 65, 83, 90, 96, 235 💬
3Cortef[2] Hydrocortisone,
Hydrocortisone cypionate		[2] Hydrocortisone ,
Hydrocortisone cypionate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83 💬
4Cortef (hydrocortisone)[1] Hydrocortisone[1] Hydrocortisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
5Cortef 5 mg[1] Hydrocortisone cypionate[1] Hydrocortisone cypionate 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
6Dehydroepiandrosterone[1] Prasterone[1] Prasterone 💬[3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[5] 49, 53, 83, 96, 113 💬
7Depot tetracosactide[1] Tetracosactide[1] Cosyntropin 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 83 💬
8Grapefruit[1] Grapefruit---[5] 6, 46, 50, 83, 97 💬
9Grapefruit Juice[1] Grapefruit---[1] 83 💬
10Hydrocortison 100 mg (Pfizer®) in 2 ml solvent----[1] 83 💬
11Hydrocortisone[2] Hydrocortisone,
Hydrocortisone acetate		[2] Hydrocortisone ,
Hydrocortisone acetate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[10] 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 💬
12Hydrocortisone 100mg/ml[1] Hydrocortisone[1] Hydrocortisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
13HYDROCORTISONE HYDROGEN SUCCINATE[3] Hydrocortisone,
Hydrocortisone succinate,
Hydrogen		[2] Hydrocortisone ,
Hydrocortisone succinate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
14HYDROCORTISONE ROUSSEL[1] Hydrocortisone[1] Hydrocortisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
15HYDROCORTISONE SODIUM PHOSPHATE[2] Hydrocortisone,
Phosphate ion		[1] Hydrocortisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 53, 81, 83 💬
16HYDROCORTISONE SODIUM SUCCINATE[1] Hydrocortisone[1] Hydrocortisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 81, 83, 97 💬
17Hydrocortisonum[1] Hydrocortisone[1] Hydrocortisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
18Hydrogen[1] Hydrogen---[6] 5, 6, 17, 83, 97, 226 💬
19Hydrokortison APL kapsel 2,5 mg----[1] 83 💬
20Isocaloric Diet----[2] 2, 83 💬
21Liquorice[1] Licorice[1] Glycyrrhiza 💬--[1] 83 💬
22MabThera[1] Rituximab[1] Rituximab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬
23Mabthera Infusion[1] Rituximab[1] Rituximab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 83 💬
24Medrone----[4] 46, 51, 83, 162 💬
25Methylprednisolone[1] Methylprednisolone[1] Methylprednisolone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[46] 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬
26Phosphate[1] Phosphate ion---[32] 2, 3, 6, 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 💬
27RITUXIMAB[1] Rituximab[1] Rituximab 💬[1] MS4A1 💬[1] Hematopoietic cell lineage 💬[48] 11, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
28Solu-Cortef[3] Hydrocortisone,
Hydrocortisone cypionate,
Hydrocortisone succinate		[3] Hydrocortisone ,
Hydrocortisone cypionate ,
Hydrocortisone succinate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83 💬
29Solu-Cortef (hydrocortisone)[1] Hydrocortisone[1] Hydrocortisone 💬[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
30Solu-Cortef 100 MG Injection[3] Hydrocortisone,
Hydrocortisone cypionate,
Hydrocortisone succinate		[3] Hydrocortisone ,
Hydrocortisone cypionate ,
Hydrocortisone succinate 💬		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83 💬
31Solu-Medrone----[3] 51, 83, 162 💬
32Synacthen Depot[1] Tetracosactide[1] Cosyntropin 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 83, 145, 222 💬
33Tetracosactide[1] Tetracosactide[1] Cosyntropin 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 83, 113, 145, 222 💬
34Tetracosactide acetate[2] Acetate,
Tetracosactide		[1] Cosyntropin 💬[1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 83, 145 💬